Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cb9f654ff-p5m67 Total loading time: 0 Render date: 2025-08-07T21:37:54.703Z Has data issue: false hasContentIssue false

Chapter 10 - Methamphetamine

from Part III - Drugs with Primarily Stimulant Effects

Published online by Cambridge University Press:  06 October 2022

Dima Abdulrahim  and
Owen Bowden-Jones
Dima Abdulrahim
Affiliation:
Programme Manager and Principal Researcher for the NEPTUNE Project, Central and North West London NHS Foundation Trust
Owen Bowden-Jones
Affiliation:
Consultant Addiction Psychiatrist, Central and North West London NHS Foundation Trust
Get access

Summary

It has been argued that globally, methamphetamine use represents the greatest challenge from all synthetic drugs. Whereas the highest prevalence of its use continues to be the US, where some commentators are suggesting it is developing into an epidemic, new markets are emerging in many parts of the world, with Southeast Asia currently emerging as the world’s fastest-growing methamphetamine market.

Information

Type
Chapter
Information
Textbook of Clinical Management of Club Drugs and Novel Psychoactive Substances
NEPTUNE Clinical Guidance
 , pp. 202 - 239
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Ben-Yehuda, O, Siecke, N. Crystal methamphetamine: a drug and cardiovascular epidemic. JACC Heart Fail 2018;6:219–221. https://doi.org/10.1016/j.jchf.2018.01.004CrossRefGoogle ScholarPubMed
World Drug Report 2019 (United Nations publication, Sales No. E.19.XI.9). Available at: https://wdr.unodc.org/wdr2019/prelaunch/WDR19_Booklet_1_EXECUTIVE_SUMMARY.pdf [last accessed 13 March 2022].Google Scholar
World Health Organization, Western Pacific Region. Harm Reduction and Brief Interventions for ATS Users (Technical Brief on Amphetamine-Type Stimulants 2). Available at: www.who.int/hiv/pub/idu/ats_brief2.pdf [last accessed 13 March 2022].Google Scholar
Panenka, WJ, Procyshyn, RM, Lecomte, T, et al. Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings. Drug Alcohol Depend 2013;129(3):167–179. https://doi.org/10.1016/j.drugalcdep.2012.11.016Google Scholar
Pérez-Mañá, C, Castells, X, Torrens, M, Capellà, D, Farre, M. Efficacy of psychostimulant drugs for amphetamine abuse or dependence. Cochrane Database Syst Rev 2013; 2(9):CD009695.Google Scholar
Newton, TF, De La Garza, R, Kalechstein, AD, Nestor, L. Cocaine and methamphetamine produce different patterns of subjective and cardiovascular effects. Pharmacol Biochem Behav 2005;82(1):90–97.Google Scholar
Weiland-Fiedler, P, Erickson, K, Waldeck, T, et al. Evidence for continuing neuropsychological impairments in depression. J Affect Disord 2004;82(2):253–258.Google Scholar
Fleckenstein, AE, Volz, TJ, Hanson, GR. Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications. Neuropharmacology 2009;56(Suppl. 1_:133–138. https://doi.org/10.1016/j.neuropharm.2008.07.002Google Scholar
Sulzer, D, Sonders, MS, Poulsen, NW, Galli, A. Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 2005;75(6):406–433.Google Scholar
Rose, ME, Grant, JE. Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions. Ann Clin Psychiatry 2008;20:145–155.CrossRefGoogle ScholarPubMed
Volkow, ND, Chang, L, Wang, GJ, et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 2001;158(3):377–382.Google Scholar
Chang, L, Cloak, C, Patterson, K, et al. Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response. Biol Psychiatry 2005;57:967–974.Google Scholar
Thompson, PM, Hayashi, KM, Simon, SL, et al. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 2004;24:6028–6036.Google Scholar
London, ED, Simon, SL, Berman, SM, et al. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry 2004;61(1):73–84.Google Scholar
Baicy, K, London ED. Corticolimbic dysregulation and chronic methamphetamine abuse. Addiction 2007;102(Suppl. 1):5–15.Google Scholar
Aron, JL, Paulus, MP. Location, location: using functional magnetic resonance imaging to pinpoint brain differences relevant to stimulant use. Addiction 2007;102(Suppl. 1):33–43.Google Scholar
Volkow, ND, Wang, GJ, Fowler, JS, et al Brain, DA D2 receptors predict reinforcing effects of stimulants in humans: replication study. Synapse 2002;46:79–82.Google Scholar
Volkow, ND, Li, TK. Drug addiction: the neurobiology of behaviour gone awry. Nat Rev Neurosci 2004;5:963–970.Google Scholar
Goldstein, RZ, Volkow, ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002;159:1642–1652.CrossRefGoogle ScholarPubMed
Brackins, T, Brahm, NC, Kissack, JC. Treatments for methamphetamine abuse: a literature review for the clinician. J Pharm Pract 2011;24(6):541–550. https://doi.org/10.1177/0897190011426557CrossRefGoogle ScholarPubMed
Sora, I, Li, B, Fumushima, S, et al. Monoamine transporter as a target molecule for psychostimulants. Int Rev Neurobiol 2009;85:29–33.Google Scholar
See www.accessdata.fda.gov/drugsatfda_docs/label/2013/005378s028lbl.pdf [last accessed 13 March 2022].Google Scholar
World Drug Report 2019 (United Nations publication, Sales No. E.19.XI.9).Google Scholar
World Drug Report 2020 (United Nations publication, Sales No. E.20.XI.6).Google Scholar
European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2019: Trends and Developments. Luxembourg, Publications Office of the European Union, 2019.Google Scholar
van Hout, MC, Hearne, E. Shake ‘N Bake: the migration of ‘Pervitin’ to Ireland. Int J Ment Health Addict 2016;15(4):919–927.CrossRefGoogle Scholar
European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2020: Trends and Developments. Luxembourg, Publications Office of the European Union, 2020.Google Scholar
European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2020: Trends and Developments. Luxembourg, Publications Office of the European Union, 2020.Google Scholar
European Monitoring Centre for Drugs and Drug Addiction. Drugs in Syringes from Six European Cities: Results from the ESCAPE Project 2017. Luxembourg, Publications Office of the European Union, 2019.Google Scholar
European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2020: Trends and Developments. Luxembourg, Publications Office of the European Union, 2020.Google Scholar
European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2020: Trends and Developments. Luxembourg, Publications Office of the European Union, 2020.Google Scholar
Mravčík V, Chomynová P, Grohmannová K, et al. National Report: The Czech Republic – 2013 Drug Situation. Praha, Úřad vlády České Republik.Google Scholar
Šefránek, M, Miovský, M. Treatment outcome evaluation in therapeutic communities in the Czech Republic: changes in methamphetamine use and related problems one year after discharge. J Groups Addict Recover 2018 (online). https://doi.org/10.1080/1556035X.2017.1280718Google Scholar
European Monitoring Centre for Drugs and Drug Addiction. European Drug Report. Trends and Developments 2015. (EMCDDA Papers). Luxembourg, Publications Office of the European Union, 2015.Google Scholar
European Monitoring Centre for Drugs and Drug Addiction. Exploring Methamphetamine Trends in Europe. (EMCDDA Papers). Luxembourg, Publications Office of the European Union, 2014a.Google Scholar
European Monitoring Centre for Drugs and Drug Addiction and Europol. Methamphetamine in Europe, EMCDDA-Europol Threat Assessment. Luxembourg, Publications Office of the European Union, 2019.Google Scholar
Brecht, ML, Greenwell, L, Anglin, MD. Methamphetamine treatment: trends and predictors of retention and completion in a large state treatment system (1992–2002). J Subst Abuse Treat 2005;29(4):295–306.Google Scholar
Jones, CM, Compton, WM, Mustaquim, D. Centre for Disease Control and Prevention. Patterns and characteristics of methamphetamine use among adults – United States, 2015–2018. Morb Mortal Wkly Rep 2020;69(12):317.Google Scholar
European Monitoring Centre for Drugs and Drug Addiction. European Drug Report: Trends and Developments. Luxembourg, Publications Office of the European Union, 2014.Google Scholar
Šefránek, M, Miovský, M. Treatment outcome evaluation in therapeutic communities in the Czech Republic: changes in methamphetamine use and related problems one year after discharge. J Groups Addict Recover 2017 (online). https://doi.org/10.1080/1556035X.2017.1280718Google Scholar
European Monitoring Centre for Drugs and Drug Addiction. Perspectives on drugs. Health and social responses for methamphetamine users. Updated 27 June 2014. Accessed 5 September 2019.Google Scholar
Jones, CM, Compton, WM, Mustaquim, D. Centre for Disease Control and Prevention. Patterns and characteristics of methamphetamine use among adults – United States, 2015–2018. Morb Mortal Wkly Rep 2020;69(12):317.Google Scholar
Palmer, A, Scott, N, Dietze, P, et al. Motivations for crystal methamphetamine-opioid co-injection/co-use amongst community-recruited people who inject drugs: a qualitative study. Harm Reduct J 2020;17:31714. https://doi.org/10.1186/s12954-020-00360-9Google Scholar
Home Office. Drug Misuse: Findings from the 2013/14 Crime Survey for England and Wales. July 2001. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/335989/drug_misuse_201314.pdf [last accessed 25 April 2022].Google Scholar
Keogh, P, Reid, D, Bourne, A, et al. Wasted Opportunities. Problematic Alcohol and Drug Use Among Gay and Bisexual Men. Available at: www.sigmaresearch.org.uk/files/report2009c.pdf [last accessed 14 March 2022].Google Scholar
Stonewall’s Gay and Bisexual Men’s Health Survey. Available at: www.stonewall.org.uk/system/files/Gay_and_Bisexual_Men_s_Health_Survey__2013_.pdf [last accessed 14 March 2022].Google Scholar
Buffin, J, Roy, A, Williams, H, Yorston, C (National LGB Drug & Alcohol Database). Part of the Picture: Lesbian, Gay and Bisexual People’s Alcohol and Drug Use in England. Substance Dependency and Help-Seeking Behaviour. UCLAN and Lesbian and Gay Foundation. Published 2012.Google Scholar
Bonell, CP, Hickson, FCI, Weatherburn, P, et al. Methamphetamine use among gay men across the UK. Int J Drug Policy 2010;21:244–246.Google Scholar
Lea, T, Kolstee, J, Lambert, S, Ness, R, Hannan, S, Holt, M. Methamphetamine treatment outcomes among gay men attending a LGBTI-specific treatment service in Sydney, Australia. PLOS ONE 2017 (online). https://doi.org/10.1371/journal.pone.0172560Google Scholar
Lea, T, Mao, L, Hopwood, M, et al.Methamphetamine use among gay and bisexual men in Australia: trends in recent and regular use from the Gay Community Periodic Surveys l. Int J Drug Policy 2016;29:66–72.Google Scholar
Buchacz, K, McFarland, W, Kellogg, TA, et al. Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco. AIDS 2005;19:1423–1424. https://doi.org/00002030-200509020-00011Google Scholar
Plankey, MW, Ostrow, DG, Stall, R, et al. The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2007;45:85–92. https://doi.org/10.1097/QAI.0b013e3180417c99Google Scholar
Thiede, H, Jenkins, RA, Carey, JW, et al. Determinants of recent HIV infection among Seattle-area men who have sex with men. Am J Public Health 2009;99(Suppl. 1):S157–164. https://doi.org/10.2105/AJPH.2006.098582Google Scholar
Glick, S, Burt, R, Moreno, C, Ketchum, J, Thiede, H. Highlights from the 2015 Seattle area National HIV Behavioral Surveillance survey of injection drug use. HIV/AIDS Epidemiology Unit, Public Health – Seattle & King County and the Infectious Disease Assessment Unit, Washington State Department of Health HIV/AIDS Epidemiology Report 2015;85:51–58.Google Scholar
Glick, S, Burt, R, Shiver, C, Moreno, C, Thiede, H. Highlights from the 2014 Seattle area National HIV Behavioral Surveillance survey of men who have sex with men. HIV/AIDS Epidemiology Unit, Public Health – Seattle & King County and the Infectious Disease Assessment Unit, Washington State Department of Health HIV/AIDS Epidemiology Report 2015;84:55–68.Google Scholar
Lima, SH, Akbarb, M, Wickershamb, JA, Kamarulzaman, A, Frederick, L. The management of methamphetamine use in sexual settings among men who have sex with men in Malaysia. Int J Drug Policy 2018;55:256–262. https://doi.org/10.1016/j.drugpo.2018.02.019Google Scholar
World Drug Report 2019 (United Nations publication, Sales No. E.19.XI.9).Google Scholar
Maxwell, S, Shahmanesh, M, Gafos, M. Chemsex behaviours among men who have sex with men: a systematic review of the literature. Int J Drug Policy 2019;63: 74–89.Google Scholar
Bourne, A, Reid, D, Hickson, F, Torres Rueda, S, Weatherburn, P. The chemsex study: drug use in sexual settings among gay and bisexual men in Lambeth, Southwark and Lewisham. London, Sigma Research, London School of Hygiene and Tropical Medicine. Published 2014. Available at:www.sigmaresearch.org.uk/chemsex [lastaccessed14March2022].Google Scholar
Bolding, G, Hart, G, Sherr, L, Elford, J. Use of crystal methamphetamine among gay men in London. Addiction 2006;101:1622–1630.Google Scholar
Forrest, D, Metsch, L, LaLota, M, Cardenas, G, Beck, D, Jeanty, Y. Crystal methamphetamine use and sexual risk behaviors among HIV-positive and HIV-negative men who have sex with men in South Florida. J Urban Health 2010;87:480–485.Google Scholar
Schwarcz, S, Scheer, S, McFarland, W, et al. Prevalence of HIV infection and predictors of high transmission sexual risk behaviors among men who have sex with men. Am J Public Health 2007;97:1067–1075.Google Scholar
Whittington, W, Collis, T, Dithmer-Schreck, D, et al. Sexually transmitted diseases and human immunodeficiency virus-discordant partnerships among men who have sex with men. Clin Infect Dis 2002;35:1010–1017.Google Scholar
Buchacz, K, McFarland, W, Kellogg, T, et al. Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco. AIDS 2005;19:1423–1424.Google Scholar
Hoenigl, M, Chaillon, A, Moore, DJ, Morris, SR, Davey, M, Smith S, J. Little, clear links between starting methamphetamine and increasing sexual risk behavior: a cohort study among men who have sex with men. J Acquir Immune Defic Syndr 2016;71:551–557.Google Scholar
Nelson Glick, S, Burt, R, Kummer, K, Tinsley, J, Banta-Green, CJ, Golden, MR. Increasing methamphetamine injection among MSM who inject drugs in King County. Washington Drug Alcohol Depend 2018;182:86–92. https://doi.org/10.1016/j.drugalcdep.2017.10.011Google Scholar
McKetin, R, Lubman, DI, Baker, A, et al.The relationship between methamphetamine use and heterosexual behaviour: evidence from a prospective longitudinal study. Addiction 2018;113:1276–1285.Google Scholar
Degenhardt, L, Grant, S, Mcketin, R, et al. Crystalline methamphetamine use and methamphetamine-related harms in Australia. Drug Alcohol Rev 2016 (online). https://doi.org/10.1111/dar.12426Google Scholar
European Monitoring Centre for Drugs and Drug Addiction and Europol. Methamphetamine in Europe, EMCDDA-Europol Threat Assessment. Luxembourg, Publications Office of the European Union, 2019.Google Scholar
Schifano, F, Corkery, JM, Cuffolo, G. Smokable (‘ice’, ‘crystal meth’) and non-smokable amphetamine-type stimulants: clinical pharmacological and epidemiological issues, with special reference to the UK. Ann Ist Super Sanita 2007;43(1):110–115.Google Scholar
McKetin, R, Kelly, E, McLaren, J. The relationship between crystalline methamphetamine use and methamphetamine dependence. Drug Alcohol Depend 2006;85(3):198–204.Google Scholar
McKetin, R, McLaren, J, Lubman, DI, Hides, L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 2006;101(10):1473–1478.Google Scholar
Barr, AM, Panenka, WJ, MacEwan, GW, et al. The need for speed: an update on methamphetamine addiction. J Psychiatry Neurosci 2006;31:301–313.Google Scholar
Gawin, FH, Ellinwood, EH Jr. Cocaine and other stimulants. Actions, abuse, and treatment. N Engl J Med 1988;318:1173–1182.Google Scholar
La Garza, De Zorick, R Heinzerling, T et al, KG. The cardiovascular and subjective effects of methamphetamine combined with gammavinylgamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers. Pharmacol Biochem Behav 2009;94:186–193.Google Scholar
Gay, GR, Sheppard, CW. Sex in the ‘drug culture’. Med Asp Hum Sex 1972;6:28–50.Google Scholar
Bell, DS, Trethowan, WH. Amphetamine addiction and disturbed sexuality. Arch Gen Psychiatry 1961;4:74–78.Google Scholar
National Institute on Drug Abuse (NIDA). Are methamphetamine abusers at risk for contracting HIV/AIDS and hepatitis B and C? (Research Report Series: Methamphetamine Abuse and Addiction). Bethesda, MD, Department of Health and Human Services, National Institutes of Health. Revised September 2006. Available at: www.nida.nih.gov/researchreports/methamph/methamph5.html#hiv [last accessed 14 March 2022].Google Scholar
Leamon, MH, Flower, K, Salo, RE, Nordahl, TE, Kranzler, HR, Galloway, GP. Methamphetamine and paranoia: the methamphetamine experience questionnaire. Am J Addict 2010;19:155–168.Google Scholar
Leslie, EM, Smirnov, A, Cherney, A, et al. Predictors of aggressive behavior while under the influence of illicit drugs among young adult methamphetamine users. Subst Use Misuse 2018;53(14):2439–2443. doi.org/10.1080/10826084.2018.1473434Google Scholar
Brecht, ML, O’Brien, A, von Mayrhauser, C, Anglin, MD. Methamphetamine use behaviors and gender differences. Addict Behav 2004;29(1):89–106.Google Scholar
Degenhardt, L, Topp, L. Crystal methamphetamine use among polydrug users in Sydney’s dance party subculture: characteristics, use patterns and associated harms. Int J Drug Policy 2003;14(1):17–24.Google Scholar
United Nations Office on Drugs and Crime (UNODC). World Drug Report 2013 (United Nations Publication, Sales No. E.13.XI.6). UNODC, 2013.Google Scholar
Lejckova, P, Mravcik, V. Mortality of hospitalized drug users in the Czech Republic. J Drug Issues 2007;37:103–118.Google Scholar
Arendt, M, Munk-Jorgensen, P, Sher, L, Jensen, SO. Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: a nationwide follow-up study of Danish substance users in treatment. Drug Alcohol Depend 2010;114:134–139.Google Scholar
Kuo, CJ, Liao, YT, Chen, WJ, Tsai, SY, Lin, SK, Chen, CC. Causes of death of patients with methamphetamine dependence: a record-linkage study. Drug Alcohol Rev 2010;30:621–628.Google Scholar
Stenbacka, M, Leifman, A, Romelsjo, A. Mortality and cause of death among 1705 illicit drug users: a 37 year follow up. Drug Alcohol Rev 2010;29:21–27.Google Scholar
Cretzmeyer, M, Sarrazin, MV, Huber, DL, Block, RI, Hall, JA. Treatment of methamphetamine abuse: research findings and clinical directions. J Subst Abuse Treat 2003;24:267–277.Google Scholar
Meredith, CW, Jaffe, C, Ang-Lee, K, Saxon, AJ. Implications of chronic methamphetamine use: a literature review. Harv Rev Psychiatry 2005;13:141–154.Google Scholar
Shearer, J, Sherman, J, Wodak, A, van Beek, I. Substitution therapy for amphetamine users. Drug Alcohol Rev 2002;21:179–185.Google Scholar
Jones, CM, Compton, WM, Mustaquim, D. Patterns and characteristics of methamphetamine use among adults – United States, 2015–2018. Centre for Disease Control and Prevention. Morb Mort Wkly Rep 2020;69(12):317.Google Scholar
Won, S, Hong, RA, Shohet, RV, Seto, TB, Parikh, NI. Methamphetamine-associated cardiomyopathy. Clin Cardiol 2013;36:737–742. https://doi.org/10.1002/clc.2219514Google Scholar
Darke, S, Duflou, J, Kaye, S. Prevalence and nature of cardiovascular disease in methamphetamine-related death: a national study. Drug Alcohol Depend 2017;179:174–179. https://doi.org/10.1016/j.drugalcdep.2017.07.001Google Scholar
Voskoboinik, A, Ihle, JF, Bloom, JE, Kaye, DM. Amphetamine-induced cardiomyopathy: patterns and predictors of recovery. Heart Lung Circ 2015 (online). https://doi.org/10.1016/j.hlc.2015.06.198Google Scholar
Kiyatkin, EA, Brown, PL, Sharma, HS. Brain edema and breakdown of the blood–brain barrier during methamphetamine intoxication: critical role of brain hyperthermia. Eur J Neurosci 2007;26:1242–1253.Google Scholar
Harris, DS, Reus, VI, Wolkowitz, OM, Mendelson, JE, Jones, RT. Altering cortisol level does not change the pleasurable effects of methamphetamine in humans. Neuropsychopharmacology 2003;28:1677–1684.Google Scholar
Vearrier, D, Greenberg, MI, Miller, SN, Okaneku, JT, Haggerty, DA. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine. Dis Mon 2012;58(2):38–89. https://doi.org/10.1016/j.disamonth.2011.09.004Google Scholar
Richards, JR, Bretz, SW, Johnson, EB, et al. Methamphetamine abuse and emergency department utilization. West J Med 1999;170(4):198–202.Google Scholar
Wijetunga, M, Bhan, R, Lindsay, J, et al. Acute coronary syndrome and crystal methamphetamine use: a case series. Hawaii Med J 2004;63(1):8–13.Google Scholar
Turnipseed, SD, Richards, JR, Kirk, JD, et al. Frequency of acute coronary syndrome in patients presenting to the emergency department with chest pain after methamphetamine use. J Emerg Med 2003;24(4):369–373.Google Scholar
Karch, SB, Stephens, BG, Ho, CH. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles. J Forensic Sci 1999;44(2):359–368.Google Scholar
Chen, JP. Methamphetamine-associated acute myocardial infarction and cardiogenic shock with normal coronary arteries: refractory global coronary microvascular spasm. J Invasive Cardiol 2007;19(4):E89–92.Google Scholar
Kevil, CG, Goeders, NE, Woolard, MD, et al. Methamphetamine use and cardiovascular disease: in search of answers. Arterioscler Thromb Vasc Biol 2019;39:1739–1746. https://doi.org/10.1161/ATVBAHA.119.312461Google Scholar
Farnsworth, TL, Brugger, CH, Malters, P. Myocardial infarction after intranasal methamphetamine. Am J Health Syst Pharm 1997;54(5):586–587.Google Scholar
Hong, R, Matsuyama, E, Nur, K. Cardiomyopathy associated with the smoking of crystal methamphetamine. JAMA 1991;265(9):1152–1154.Google Scholar
Karch, SB. The unique histology of methamphetamine cardiomyopathy: a case report. Forensic Sci Int 2011;212(1–3):e1–4. https://doi.org/10.1016/j.forsciint.2011.04.028Google Scholar
Diercks, DB, Fonarow, GC, Kirk, JD, et al. ADHERE Scientific Advisory Committee and Investigators. Illicit stimulant use in a United States heart failure population presenting to the emergency department (from the Acute Decompensated Heart Failure National Registry Emergency Module). Am J Cardiol 2008;102(9):1216–1219. https://doi.org/10.1016/j.amjcard.2008.06.045Google Scholar
Haning, W, Goebert, D. Electrocardiographic abnormalities in methamphetamine abusers. Addiction 2007;102(Suppl. 1):70–75.Google Scholar
Islam, MN, Jesmine, K, Sn, Kong Molh, A, et al. Histopathological studies of cardiac lesions after long term administration of methamphetamine in high dosage – Part II. Leg Med 2009;11(Suppl. 1):S147–150.Google Scholar
Swalwell, CI, Davis, GG. Methamphetamine as a risk factor for acute aortic dissection. J Forensic Sci 1999;44(1):23–26.Google Scholar
Kaye, S, McKetin, R, Duflou, J, Darke, S. Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction 2007;102(8):1204–1211.Google Scholar
Zhu, Z, Osman, S, Stradling, D, et al. Clinical characteristics and outcomes of methamphetamine-associated versus non-methamphetamine intracerebral hemorrhage. Sci Rep 2020;10:6375.Google Scholar
Albertson, TE, Derlet, RW, Van Hoozen, BE. Methamphetamine and the expanding complications of amphetamines. West J Med 1999;170:214–219.Google Scholar
Darke, S, Kaye, S, McKetin, R, Duflou, J. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev 2008;27:253–262.Google Scholar
Perez, Jr JA, Arsura, EL, Strategos, S. Methamphetamine-related stroke: four cases. J Emerg Med 1999;17:469–471.Google Scholar
Lappin, JM, Darke, S, Farrell M. Stroke and methamphetamine use in young adults: a review. J Neurol Neurosurg Psychiatry 2017;88(12):1079–1091.Google Scholar
Darke, S, Lappin, J, Kaye, S, Duflou, J. Clinical characteristics of fatal methamphetamine‐related stroke: a national study. J Forensic Sci 2018;63(3):735–739. https://doi.org/10.1111/1556-4029.13620Google Scholar
Eliveha, J, Vindhyal, S, Vindhyal, M. Cardiac and systemic thrombus caused by drug abuse. Case Rep Cardiol 2019;2019. https://doi.org/10.1155/2019/5083624Google Scholar
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The Levels of Use of Opioids, Amphetamines and Cocaine and Associated Levels of Harm: Summary of Scientific Evidence. Published March 2014.Google Scholar
Richards, JR, Wang, CG, Fontenette, RW, Stuart, RP, McMahon, KF, Turnipseed, SD. Rhabdomyolysis, methamphetamine, amphetamine and MDMA use: associated factors and risks. J Dual Diagn 2020;16(4):429–437.Google Scholar
Richards, JR, Johnson, EB, Stark, RW, et al. Methamphetamine abuse and rhabdomyolysis in the ED: a 5-year study. Am J Emerg Med 1999;17(7):681–685.Google Scholar
Angrist, B, Sathananthan, G, Wilk, S, Gershon, S. Amphetamine psychosis: behavioral and biochemical aspects. J Psychiatr Res 1974;11:13–23.Google Scholar
Bell, DS. The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry 1973;29(1):35–40.Google Scholar
Griffith, JD. Experimental psychosis induced by the administration of d-amphetamine. In: Costa, E, Garattini, S, (eds.), Amphetamine and Related Compounds. New York, Raven Press, 1970.Google Scholar
Marshall, BD, Werb, D. Health outcomes associated with methamphetamine use among young people: a systematic review. Addiction 2010;105(6):991–1002.Google Scholar
Degenhardt, L, Whiteford, H, Hall, WD. The Global Burden of Disease projects: what have we learned about illicit drug use and dependence and their contribution to the global burden of disease. Drug Alcohol Rev 2014;33(1):4–12.Google Scholar
McKetina, R, Leunga, J, Stockings, E, et al.Mental health outcomes associated with the use of amphetamines: a systematic review and meta-analysis. Clin Med 2019; 16:81–97. https://doi.org/10.1016/j.eclinm.2019.09.0142589-5370Google Scholar
Angrist, B, Sathananthan, G, Wilk, S, Gershon, S. Amphetamine psychosis: behavioral and biochemical aspects. J Psychiatr Res 1974;11:13–23.Google Scholar
Bell, DS. The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry 1973;29(1):35–40.Google Scholar
Griffith, JD. Experimental psychosis induced by the administration of d-amphetamine. In: Costa, E, Garattini, S, (eds.), Amphetamine and Related Compounds. New York, Raven Press, 1970.Google Scholar
McKetin, R, Dawe, S, Burns, RA, et al. The profile of psychiatric symptoms exacerbated by methamphetamine use. Drug Alcohol Depend 2016;161:104–109.Google Scholar
See for example: Hoenigl, M, Chaillon, A, Moore, DJ, Morris, SR, Smith, DM, Little, SJ. Clear links between starting methamphetamine and increasing sexual risk behavior: a cohort study among men who have sex with men. J Acquir Immune Defic Syndr 2016;71(5):551–557. https://doi.org/10.1097/QAI.0000000000000888Google Scholar
Greenwood, GL, White, EW, Page-Shafer, K, et al. Correlates of heavy substance use among young gay and bisexual men: the San Francisco Young Men’s Health Study. Drug Alcohol Depend 2001;61:105–112.Google Scholar
Maxwell, S, Shahmanesh, M, Gafos, M. Chemsex behaviours among men who have sex with men: a systematic review of the literature. Int J Drug Policy 2019;63: 74–89.Google Scholar
Maxwell, S, Shahmanesh, M, Gafos, M. Chemsex behaviours among men who have sex with men: a systematic review of the literature. Int J Drug Policy 2019;63: 74–89.Google Scholar
Bourne, A, Reid, D, Hickson, F, et al. Illicit drug use in sexual settings (‘chemsex’) and HIV/STI transmission risk behaviour among gay men in South London: findings from a qualitative study. Sex Transm Infect 2015;91(8):564–568.Google Scholar
Perelló, R, Aused, M, Saubí, N, et al. Acute street drug poisoning in the patient with human immunodeficiency virus infection: the role of chemsex. Emergencias: Revista de la Sociedad Espanola de Medicina de Emergencias 2018;30(6):405–407.Google Scholar
Graf, N, Dichtl, A, Deimel, D, Sander, D, Stöver, H. Chemsex among men who have sex with men in Germany: motives, consequences and the response of the support system. Sex Health 2018;15:151–156. https://doi.org/10.1071/SH17142Google Scholar
Kenyon, C, Wouters, K, Platteau, T, et al. Increases in condomless chemsex associated with HIV acquisition in MSM but not heterosexuals attending a HIV testing center in Antwerp, Belgium. AIDS Res Ther 2018;15:14. https://doi.org/10.1186/s12981-018-0201-3Google Scholar
Glynn, RW, Byrne, N, O’Dea, S, Shanley, A. Chemsex, risk behaviours and sexually transmitted infections among men who have sex with men in Dublin, Ireland. Int J Drug Policy 2017 (online). https://doi.org/10.1016/j.drugpo.2017.10.008Google Scholar
Anzillotti, L, Calò, A, Banchini, et al. Mephedrone and chemsex: a case report. Leg Med 2020;42:101640.Google Scholar
Giorgetti, R, Tagliabracci, A, Schifano, F, Zaami, S, Marinelli, E, Busardò, FP. when ‘chems’ meet sex: a rising phenomenon called ‘chemsex’. Curr Neuropharmacol 2017;15(5):762–770.Google Scholar
Bourne, A, Reid, D, Hickson, F, et al. Illicit drug use in sexual settings (‘chemsex’) and HIV/STI transmission risk behaviour among gay men in South London: findings from a qualitative study. Sex Transm Infect 2015;91(8):564–568.Google Scholar
Perelló, R, Aused, M, Saubí, N, et al. Acute street drug poisoning in the patient with human immunodeficiency virus infection: the role of chemsex. Emergencias: Revista de la Sociedad Espanola de Medicina de Emergencias 2018;30(6):405–407.Google Scholar
Kirby, T, Thornber-Dunwell, M. High-risk drug practices tighten grip on London gay scene. Lancet 2013;381(9861):101–102.Google Scholar
Saxton, P, Newcombe, D, Ahmed, A, Dickson, N, Hughes, A. Illicit drug use among New Zealand gay and bisexual men: prevalence and association with sexual health behaviours. Drug Alcohol Rev 2018;37:180–187. https://doi.org/10.1111/dar.12536Google Scholar
Semple, SJ, Patterson, TL, Grant, I. Motivations associated with methamphetamine use among HIV men who have sex with men. J Subst Abuse Treat 2002;22(3):149–156.Google Scholar
Rhodes, T, Quirk, A. Drug users’ sexual relationships and the social organization of risk: the sexual relationship as a site of risk management. Soc Sci Med 1998;46(2):157–169.Google Scholar
Colfax, GN, Santos, GM, Das, M, et al. Mirtazapine to reduce methamphetamine use: a randomized controlled trial. Arch Gen Psychiatry 2011;68:1168–1175.Google Scholar
Mansergh, G, Colfax, GN, Marks, G, Rader, M, Guzman, R, Buchbinder, S. The Circuit Party Men’s Health Survey: findings and implications for gay and bisexual men. Am J Public Health 2001;91:953–958.Google Scholar
Molitor, F, Ruiz, JD, Flynn, N, Mikanda, JN, Sun, RK, Anderson, R. Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. Am J Drug Alcohol Abuse 1999;25:475–493.Google Scholar
Shoptaw, S, Reback, CJ. Methamphetamine use and infectious disease-related behaviors in men who have sex with men: implications for interventions. Addiction 2007;102(Suppl. 1):130–135.Google Scholar
Drumright, LN, Gorbach, PM, Little, SJ, Strathdee, SA. Associations between substance use, erectile dysfunction medication and recent HIV infection among men who have sex with men. AIDS Behav 2009;13:328–336. https://doi.org/10.1007/s10461-007-9330-8Google Scholar
Plankey, MW, Ostrow, DG, Stall, R, et al. The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2007;45(1):85–92. https://doi.org/10.1097/QAI.0b013e3180417c99Google Scholar
Shoptaw, S, Reback, CJ. Associations between methamphetamine use and HIV infection in men who have sex with men: a model for guiding public policy. J Urban Health 2006;83(6):1151–1157. https://doi.org/10.1007/s11524-006-9119-5Google Scholar
Rajasingham, R, Mimiaga, MJ, White, JM, Pinkston, MM, Baden, RP, Mitty, JA. A systematic review of behavioral and treatment outcome studies among HIV-infected men who have sex with men who abuse crystal methamphetamine. AIDS Patient Care STDS 2012;26(1):36–52. https://doi.org/10.1089/ apc.2011.0153Google Scholar
Carey, J, Mejia, R, Bingham, T, et al. Drug use, high-risk sex behaviors, and increased risk for recent HIV infection among men who have sex with men in Chicago and Los Angeles. AIDS Behav 2009;13:1084–1096.Google Scholar
Halkitis, P, Mukherjee, P, Palamar, J. Longitudinal modelling of methamphetamine use and sexual risk behaviors in gay and bisexual men. AIDS Behav 2009;13:783–791.Google Scholar
Wong, W, Chow, JK, Kent, CK, Klausner, JD. Risk factors for early syphilis among gay and bisexual men seen in an STD clinic: San Francisco, 2002–2003. Sex Transm Dis 2005;32(7):458–463.Google Scholar
Reback, CJ, Grella, CE. HIV risk behaviors of gay and bisexual male methamphetamine users contacted through street outreach. J Drug Issues 1999;29:155–166.Google Scholar
Colfax, GN, Mansergh, G, Guzman, R, et al. Drug use and sexual risk behavior among gay and bisexual men who attend circuit parties: a venue-based comparison. J Acquir Immune Defic Syndr 2001;28(4):373–379.Google Scholar
Colfax, G, Vittinghoff, E, Husnik, MJ, et al. EXPLORE Study Team. Substance use and sexual risk: a participant- and episode-level analysis among a cohort of men who have sex with men. Am J Epidemiol 2004;159(10):1002–1012.Google Scholar
Frosch, D, Shoptaw, S, Huber, A, Rawson, RA, Ling, W. Sexual HIV risk among gay and bisexual male methamphetamine abusers. J Subst Abuse Treat 1996;13(6):483–486.Google Scholar
Gorman, EM, Morgan, P, Lambert, EY. Qualitative research considerations and other issues in the study of methamphetamine use among men who have sex with other men. NIDA Res Monogr 1995;157:156–181.Google Scholar
Halkitis, PN, Parsons, JT, Stirratt, MJ. A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men. J Homosexuality 2001;41:17–35.Google Scholar
Paul, JP, Stall, R, Davis, F. Sexual risk for HIV transmission among gay/bisexual men in substance abuse treatment. AIDS Educ Prev 1993;5:11–24.Google Scholar
Peck, JA, Shoptaw, S, Rotheram-Fuller, E, Reback, CJ, Bierman, B. HIV-associated medical, behavioral, and psychiatric characteristics of treatment-seeking, methamphetamine-dependent men who have sex with men. J Addict Dis 2005;24:115–132.Google Scholar
Reback, CJ, Larkins, S, Shoptaw, S. Changes in the meaning of sexual risk behaviors among gay and bisexual male methamphetamine abusers before and after drug treatment. AIDS Behav 2004;8:87–98.Google Scholar
Shoptaw, S, Reback, CJ, Frosch, DL, Rawson, RA. Stimulant abuse treatment as HIV prevention. J Addict Dis 1998;17:19–32.Google Scholar
Davis, LE, Kalousek, G, Rubenstein, E. Hepatitis associated with illicit use of intravenous methamphetamine. Public Health Rep 1970;85:809–813.Google Scholar
Greenwell, L, Brecht, ML. Self-reported health status among treated methamphetamine users. Am J Drug Alcohol Abuse 2003;29:75–104.Google Scholar
Harkess, J, Gildon, B, Istre, GR. Outbreaks of hepatitis A among illicit drug users, Oklahoma, 1984–98 [comment]. Am J Public Health 1989;79:463–466.Google Scholar
Hutin, YJ, Sabin, KM, Hutwagner, LC, et al. Multiple modes of hepatitis A virus transmission among methamphetamine users. Am J Epidemiol 2000;152:186–192.Google Scholar
Koester, S, Glanz, J, Barón, A. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. AIDS Behav 2005;9:27–39.Google Scholar
Meyer, JM. Prevalence of hepatitis A, hepatitis B, and HIV among hepatitis C-seropositive state hospital patients: results from Oregon State Hospital. J Clin Psychiatry 2003;64:540–545.Google Scholar
Urbina, A, Jones, K. Crystal methamphetamine, its analogues, and HIV infection: medical and psychiatric aspects of a new epidemic. Clin Infect Dis 2004;38:890–894.Google Scholar
Vogt, TM, Perz, JF, Van Houten, CKJ, et al. An outbreak of hepatitis B virus infection among methamphetamine injectors: the role of sharing injection drug equipment. Addiction 2006;101:726–730.Google Scholar
Rudy, ET, Shoptaw, S, Lazzar, M, Bolan, RK, Tilekar, SD, Kerndt, PR. Methamphetamine use and other club drug use differ in relation to HIV status and risk behavior among gay and bisexual men. Sex Transm Dis 2009;36:693–695.Google Scholar
Burcham, JL, Tindall, B, Marmor, M, Cooper, DA, Berry, G, Penny, R. Incidence and risk factors for human immunodeficiency virus seroconversion in a cohort of Sydney homosexual men. Med J Aust 1989;150(11):634–639.Google Scholar
Chesney, MA, Barrett, DC, Stall, R. Histories of substance use and risk behavior: precursors to HIV seroconversion in homosexual men. Am J Public Health 1998;88(1):113–116.Google Scholar
Koblin, BA, Husnik, MJ, Colfax, G, et al. Risk factors for HIV infection among men who have sex with men. AIDS 2006;20(5):731–739.Google Scholar
Menza, TW, Hughes, JP, Celum, CL, Golden, MR. Prediction of HIV acquisition among men who have sex with men. Sex Transm Dis 2009;36(9):547–555.Google Scholar
Bousman, CA, Cherner, M, Ake, C, et al. Negative mood and sexual behavior among non-monogamous men who have sex with men in the context of methamphetamine and HIV. J Affect Disord 2009;119:84–91.Google Scholar
Mayer, KH, O’Cleirigh, C, Skeer, M, et al. Which HIV-infected men who have sex with men in care are engaging in risky sex and acquiring sexually transmitted infections: findings from a Boston community health centre. Sex Transm Infect 2010;86:66–70.Google Scholar
Mansergh, G, Shouse, RL, Marks, G, et al. Methamphetamine and sildenafil (Viagra) use are linked to unprotected receptive and insertive anal sex, respectively, in a sample of men who have sex with men. Sex Transm Infect 2006;82:131–134.Google Scholar
Halkitis, P, Shrem, M, Martin, F. Sexual behavior patterns of methamphetamine-using gay and bisexual men. Subst Use Misuse 2005;40:703–719.Google Scholar
Marquez, C, Mitchell, SJ, Hare, CB, John, M, Klausner, JD. Methamphetamine use, sexual activity, patient–provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004–2006. AIDS Care 2009;21:575–582.Google Scholar
Wohl, A, Frye, D, Johnson, D. Demographic characteristics and sexual behaviors associated with methamphetamine use among MSM and non-MSM diagnosed with AIDS in Los Angeles County. AIDS Behav 2008;12:705–712.Google Scholar
Spindler, HH, Scheer, S, Chen, SY, et al. Viagra, methamphetamine, and HIV risk: results from a probability sample of MSM, San Francisco. Sex Transm Dis 2007;34:586–591.Google Scholar
Semple, S, Zians, J, Grant, I, Patterson, T. Sexual compulsivity in a sample of HIV-positive methamphetamine-using gay and bisexual men. AIDS Behav 2006;10:587–598.Google Scholar
Hall, W, Hando, J. Route of administration and adverse effects of amphetamine use among young adults in Sydney, Australia. Drug Alcohol Rev 1994;13:277–284.Google Scholar
Klee, H. HIV risks for women drug injectors: heroin and amphetamine users compared. Addiction 1993;88:1055–1062.Google Scholar
Bourne, A, Reid, D, Hickson, F, Torres Rueda, S, Steinberg, P, Weatherburn, P. A perfect storm? Modern technological and structural facilitators of drug use during sex among gay men in London. Poster presentation, 2014. Available at: https://sigmaresearch.org.uk/files/Adam_Bourne_IAS_Melbourne_2014e_poster.pdf [last accessed 25 April 2022].Google Scholar
Bourne, A, Reid, D, Torres Rueda, S, Hickson, F, Steinberg, P, Weatherburn, P. A perfect storm? Modern technological and structural facilitators of drug use during sex among gay men in London. XX International AIDS Conference, Melbourne, Australia, 20–25 July 2014 (poster). Available at: http://sigmaresearch.org.uk/presentations/item/talk2014eGoogle Scholar
Jennings, J, Tilchin, C, Schumacher, C, et al. Sex, drugs and the Internet – the perfect storm for syphilis transmission among black gay and bisexual men (BMSM) 1. Sex Transm Infect 2019;95(Suppl. 1):A1–A376.Google Scholar
Hatfield, LA, Horvath, KJ, Jacoby, SM, Simon Rosser, BR. Comparison of substance use and risky sexual behaviour among a diverse sample of urban, HIV-positive men who have sex with men. J Addict Dis 2009;28:208–218.Google Scholar
Patterson, T, Semple, S, Zians, J, Strathdee, S. Methamphetamine-using HIV-positive men who have sex with men: correlates of polydrug use. J Urban Health 2005;82:i120–126.Google Scholar
Semple, SJ, Strathdee, SA, Zians, J, Patterson, TL. Sexual risk behavior associated with co-administration of methamphetamine and other drugs in a sample of HIV-positive men who have sex with men. Am J Addict 2009;18:65–72.Google Scholar
Semple, SJ, Strathdee, SA, Zians, J, Patterson, TL. Social and behavioral characteristics of HIV-positive MSM who trade sex for methamphetamine. Am J Drug Alcohol Abuse 2010;36:325–331.Google Scholar
Semple, S, Zians, J, Strathdee, S, Patterson, T. Sexual marathons and methamphetamine use among HIV-positive men who have sex with men. Arch Sex Behav 2009;38:583–590.Google Scholar
Semple, S, Strathdee, S, Zians, J, Patterson, T. Factors associated with sex in the context of methamphetamine use in different sexual venues among HIV-positive men who have sex with men. BMC Public Health 2010;10:178.Google Scholar
Semple, SJ, Patterson, TL, Grant, I. Binge use of methamphetamine among HIV-positive men who have sex with men: pilot data and HIV prevention implications. AIDS Educ Prev 2003;15:133.Google Scholar
Halkitis, PN, Mukherjee, PP, Palamar, JJ. Multi-level modelling to explain methamphetamine use among gay and bisexual men. Addiction 2007;102(Suppl. 1):76–83.Google Scholar
Waldo, CR, McFarland, W, Katz, MH, MacKellar, D, Valleroy, LA. Very young gay and bisexual men are at risk for HIV infection: the San Francisco Bay Area Young Men’s Survey II. J Acquir Immune Defic Syndr 2000;24:168–174.Google Scholar
Woody, GE, Donnell, D, Seage, GR, et al. Non-injection substance use correlates with risky sex among men having sex with men: data from HIVNET. Drug Alcohol Depend 1999;53:197–205.Google Scholar
Corsi, KF, Booth, RE. HIV sex risk behaviors among heterosexual methamphetamine users: literature review from 2000 to present. Curr Drug Abuse Rev 2008;1(3):292–296.Google Scholar
Molitor, F, Truax, SR, Ruiz, JD, Sun, RK. Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. West J Med 1998;168(2):93–97.Google Scholar
Semple, SJ, Patterson, TL, Grant, I. Determinants of condom use stage of change among heterosexually-identified methamphetamine users. AIDS Behavior 2004;8:391–400.Google Scholar
Semple, SJ, Patterson, TL, Grant, I. The context of sexual risk behavior among heterosexual methamphetamine users. Addict Behav 2004;29:807–810.Google Scholar
Morb, M. Methamphetamine use and HIV risk behaviors among heterosexual men – preliminary results from five northern California counties, December 2001–November 2003. Morb Mort Wkly Rep 2006;55(10):273–277.Google Scholar
Copeland, AL, Sorensen, JL. Differences between methamphetamine users and cocaine users in treatment. Drug Alcohol Depend 2001;62(1):91–95.Google Scholar
Maxwell, JC, Rutkowski, BA. The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992–2007. Drug Alcohol Rev 2008;27:229–235.Google Scholar
Braine, N, Des Jarlais, DC, Goldblatt, C, Zadoretzky, C, Turner, C. HIV risk behavior among amphetamine injectors at US syringe exchange programs. AIDS Educ Prev 2005;17:515–524.Google Scholar
Hall, W, Darke, S, Ross, M, Wodak, A. Patterns of drug use and risk-taking among injecting amphetamine and opioid drug users in Sydney, Australia. Addiction 1993;88:509–516.Google Scholar
Kaye, S, Darke, S. A comparison of the harms associated with the injection of heroin and amphetamines. Drug Alcohol Depend 2000;58:189–195.Google Scholar
McKetin, R, Ross, J, Kelly, E, et al. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants. Drug Alcohol Rev 2008;27:277–285.Google Scholar
Fairbairn, N, Wood, E, Stoltz, JA, Li, K, Montaner, JS, Kerr, T. Crystal methamphetamine use associated with non-fatal overdose among a cohort of injection drug users in Vancouver. Public Health 2008;122:70–78.Google Scholar
Fairbairn, N, Kerr, T, Buxton, JA, Li, K, Montaner, JS, Wood, E. Increasing use and associated harms of crystal methamphetamine injection in a Canadian setting. Drug Alcohol Depend 2007;88:313–316.Google Scholar
Hayashi, K, Wood, E, Suwannawong, P, Kaplan, K, Qi, J, Kerr, T. Methamphetamine injection and syringe sharing among a community-recruited sample of injection drug users in Bangkok, Thailand. Drug Alcohol Depend 2011;115:145–149.Google Scholar
Lorvick, J, Martinez, A, Gee, L, Kral, AH. Sexual and injection risk among women who inject methamphetamine in San Francisco. J Urban Health 2006;83:497–505.Google Scholar
Semple, SJ, Patterson, TL, Grant, I. A comparison of injection and non-injection methamphetamine using HIV-positive men who have sex with men. Drug Alcohol Depend 2004;76(2):203–212.Google Scholar
Hall, W, Hando, J, Darke, S, Ross, J. Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction 1996;91:81–87.Google Scholar
Zweben, JE, Cohen, JB, Christian, D, et al. Psychiatric symptoms in methamphetamine users. Am J Addict 2004;13:181–190.Google Scholar
Darke, S, Kaye, S, Duflou, J, Lappin, J. Completed suicide among methamphetamine users: a national study. Suicide Life Threat Behav 2019;49(1):328–337. https://doi.org/10.1111/sltb.12442Google Scholar
Glasner-Edwards, S, Mooney, LJ, Marinelli-Casey, P, Hillhouse, M, Ang, A, Rawson, R. Risk factors for suicide attempts in methamphetamine-dependent patients. Am J Addict 2008;17:24–27.Google Scholar
Marshall, BD, Grafstein, E, Buxton, JA, et al. Frequent methamphetamine injection predicts emergency department utilization among street-involved youth. Public Health 2012;126(1):47–53. https://doi.org/10.1016/j.puhe.2011.09.011Google Scholar
Darke, S, Hall, W. Levels and correlates of polydrug use among heroin users and regular amphetamine users. Drug Alcohol Depend 1995;39(3):231–235.Google Scholar
Grant, BF, Harford, TC. Concurrent and simultaneous use of alcohol with cocaine: results of national survey. Drug Alcohol Depend 1990;25:97–104.Google Scholar
Druglnfo Clearinghouse. Methamphetamine. Prevention Research Quarterly: Current Evidence Evaluated. 2008;24(2). Available at: www.druginfo.adf.org.auGoogle Scholar
Cook, CE, Jeffcoat, AR, Sadler, BM, et al. Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans. Drug Metab Dispos 1992;20:856–862.Google Scholar
Lai, MW, Klein-Schwartz, W, Rodgers, GC, et al. 2005 Annual report of the American Association of Poison Control Centers’ national poisoning and exposure database. Clin Toxicol 2006;44:803–932.Google Scholar
Chan, P, Chen, JH, Lee, MH, Deng, JF. Fatal and nonfatal methamphetamine intoxication in the intensive care unit. J Toxicol Clin Toxicol 1994;32:147–155.Google Scholar
Kerr, T, Wood, E, Grafstein, E, et al. High rates of primary care and emergency department use among injection drug users in Vancouver. J Public Health 2005;27:62e6.Google Scholar
Hendrickson, RG, Cloutier, RL, Fu, R. The association of controlling pseudoephedrine availability on methamphetamine-related emergency department visits. Acad Emerg Med 2010;17:1216–1222.Google Scholar
Hendrickson, RG, Cloutier, RL, McConnell, KJ. Methamphetamine-related emergency department utilization and cost. Acad Emerg Med 2008;15:23–31.Google Scholar
Schep, LJ, Slaughter, RJ, Beasley, MG. The clinical toxicology of methamphetamine. Clin Toxicol 2010;48:675–694.Google Scholar
Glasner-Edwards, S, Mooney, LJ, Marinelli-Casey, P, et al. Clinical course and outcomes of methamphetamine-dependent adults with psychosis. J Subst Abuse Treat 2008;35:445–450.Google Scholar
Mahoney, JJ, Kalechstein, AD, De La Garza, R, Newton, TF. Presence and persistence of psychotic symptoms in cocaine- versus methamphetamine-dependent participants. Am J Addict 2008;17:83–98.Google Scholar
McKetin, R, McLaren, J, Lubman, DI, Hides, L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 2008;17:24–27.Google Scholar
Iwanami, A, Sugiyama, A, Kuroki, N, et al. Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan – a preliminary report. Acta Psychiatr Scand 1994;89:428–432.Google Scholar
Nakama, H, Chang, L, Cloak, C, et al. Association between psychiatric symptoms and craving in methamphetamine users. Am J Addict 2008;17:441–446.Google Scholar
West, PL, McKeown, NJ, Hendrickson, RG. Methamphetamine body stuffers: an observational case series. Ann Emerg Med 2010;55:190–197.Google Scholar
Glasner-Edwards, S, Marinelli-Casey, P, Hillhouse, M, et al. Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up. J Nerv Ment Dis 2009;197:225–231.Google Scholar
Sutcliffe, CG, German, D, Sirirohn, B, et al. Patterns of methamphetamine use and symptoms of depression among young adults in northern Thailand. Drug Alcohol Depend 2009;101:146–151.Google Scholar
Pasic, J, Russo, JE, Ries, RK, Roy-Byrne, PP. Methamphetamine users in the psychiatric emergency services: a case-control study. Am J Drug Alcohol Abuse 2007;33:675–686.Google Scholar
Bunting, PJ, Fulde, GWO, Forster, SL. Comparison of crystalline methamphetamine (‘ice’) users and other patients with toxicology-related problems presenting to a hospital emergency department. Med J Austr 2007;187:564–566.Google Scholar
Cloutier, RL, Hendrickson, RG, Fu, RR, Blake, B. Methamphetamine-related psychiatric visits to an urban academic emergency department: an observational study. J Emerg Med 2013;45(1):136–142. https://doi.org/10.1016/j.jemermed.2012.11.094Google Scholar
Isoardi, KZ, Ayles, SF, Harris, K, Finch, CJ, Page, CB. Methamphetamine presentations to an emergency department: management and complications. Emerg Med Australas 2019;31:593–599.Google Scholar
Unadkat, A, Subasinghe, S, Harvey, RJ, Castle, DJ. Methamphetamine use in patients presenting to emergency departments and psychiatric inpatient facilities: what are the service implications? Australas Psychiatry 2019;27(1):14–17.Google Scholar
Isoardi, KZ, Ayles, SF, Harris, K, Finch, CJ, Page, CB. Methamphetamine presentations to an emergency department: management and complications. Emerg Med Australas 2019;31:593–599.Google Scholar
McKetin, R, Baker, AL, Dawe, S, Voce, A, Lubman, DI. Differences in the symptom profile of methamphetamine‐related psychosis and primary psychotic disorders. Psychiatry Res 2017;251:349–354. https://doi.org/10.1016/j.psychres.2017.02.028Google Scholar
Shoptaw, SJ, Kao, U, Ling, W. Treatment for amphetamine psychosis. Cochrane Database Syst Rev 2009;1:CD003026. https://doi.org/10.1002/14651858.CD003026.pub3Google Scholar
Wang, G, Zhang, Y, Zhang, S, et al. Aripiprazole and risperidone for treatment of methamphetamine‐associated psychosis in Chinese patients. J Subst Abuse Treat 2016;62:84–88. https://doi.org/10.1016/j.jsat.2015.11.009Google Scholar
Chiang, M, Lombardi, D, Du, J, et al. Methamphetamine‐associated psychosis: clinical presentation, biological basis, and treatment options. Hum Psychopharmacol Clin Exp 2019;2019:e2710. https://doi.org/10.1002/hup.2710Google Scholar
McKetina, R, Leunga, J, Stockings, E, et al.Mental health outcomes associated with the use of amphetamines: a systematic review and meta-analysis. Clin Med 2019; 16: 81–97. https://doi.org/10.1016/j.eclinm.2019.09.0142589-5370Google Scholar
Jones, CM, Compton, WM, Mustaquim, D. Patterns and characteristics of methamphetamine use among adults – United States, 2015–2018. Centre for Disease Control and Prevention. Morb Mort Wkly Rep 2020;69(12):317.Google Scholar
Bruehl, AM, Lende, DH, Schwartz, M, Sterk, CE, Elifson, K. Craving and control: methamphetamine users’ narratives. J Psychoactive Drugs 2006;Suppl. 3:385–392.Google Scholar
Newton, TF, Roache, JD, La, De Garza, R, et al. Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology 2006;31(7):1537–1544.Google Scholar
Tolliver, BK, McRae-Clark, AL, Saladin, M, et al. Determinants of cue-elicited craving and physiologic reactivity in methamphetamine-dependent subjects in the laboratory. Am J Drug Alcohol Abuse 2010;36:106–113.Google Scholar
Hartz, DT, Frederick-Osborne, SL, Galloway, GP. Craving predicts use during treatment for methamphetamine dependence: a prospective, repeated measures, within-subject analysis. Drug Alcohol Depend 2001;63(3):269–276.Google Scholar
Sadek, JR, Vigil, O, Grant, I, Heaton, RK. The impact of neuropsychological functioning and depressed mood on functional complaints in HIV-1 infection and methamphetamine dependence. J Clin Exp Neuropsychol 2007;29(3):266−276.Google Scholar
Rendell, PG, Mazur, M, Henry, JD. Prospective memory impairment in former users of methamphetamine. Psychopharmacology 2009;203(3):609−616.Google Scholar
Cheng, M, Liu, Q, Wang, Y, et al. MMP-9-BDNF pathway is implicated in cognitive impairment of male individuals with methamphetamine addiction during early withdrawal. Behav Brain Res 2019;366:29−35. doi.org/10.1016/j.bbr.2019.03.020Google Scholar
Kalechstein, AD, Newton, TF, Green, M. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J Neuropsychiatry Clin Neurosci 2003;15:215–220.Google Scholar
Simon, SL, Dacey, J, Glynn, S, Rawson, R, Ling, W. The effect of relapse on cognition in abstinent methamphetamine abusers. J Subst Abuse Treat 2004;27:59–66.Google Scholar
Simon, SL, Domier, CP, Sim, T, Richardson, K, Rawson, RA, Ling, W. Cognitive performance of current methamphetamine and cocaine abusers. J Addict Dis 2002;21:61–74.Google Scholar
Kamei, H, Nagai, T, Nakano, H, et al. Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK1/2 activation in the prefrontal cortex of mice. Biol Psychiatry 2006;59:75–84.Google Scholar
Kitanaka, J, Kitanaka, N, Takemura, M. Neurochemical consequences of dysphoric state during amphetamine withdrawal in animal models: a review. Neurochem Res 2008;33:204–219.Google Scholar
Marshall, JF, Belcher, AM, Feinstein, EM, O’Dell, SJ. Methamphetamine-induced neural and cognitive changes in rodents. Addiction 2007;102:61–69.Google Scholar
Nordahl, TE, Salo, R, Leamon, M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition. J Neuropsychiatry Clin Neurosci 2003;15:317–325.Google Scholar
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Exploring Methamphetamine Trends in Europe (EMCDDA Paper). Lisbon, Publications Office of the European Union, 2014.Google Scholar
Henry, BL, Minassian, A, Perry, W. Effect of methamphetamine dependence on everyday functional ability. Addict Behav 2010;35(6):593–598. https://doi.org/10.1016/j.addbeh.2010.01.013Google Scholar
Fitzpatrick, RE, Rubenis, AJ, Verdejo-Garcia, A. Cognitive deficits in methamphetamine addiction: independent contributions of dependence and intelligence. Drug Alcohol Depend 2020;209:107891.Google Scholar
Shoptaw, SJ, Kao, U, Heinzerling, K, Ling, W. Treatment for amphetamine withdrawal (review). Cochrane Database Syst Rev 2009;(2):CD003021. https://doi.org/10.1002/14651858.CD003021.pub2Google Scholar
McGregor, C, Srisurapanont, M, Jittiwutikarn, J, Laobhripatr, S, Wongtan, T, White, JM. The nature, time course and severity of methamphetamine withdrawal. Addiction 2005;100(9):1320–1329.Google Scholar
Homer, BD, Solomon, TM, Moeller, RW, Mascia, A, DeRaleau, L, Halkitis, PN. Methamphetamine abuse and impairment of social functioning: a review of the underlying neurophysiological causes and behavioral implications. Psychol Bull 2008;134:301–310.Google Scholar
Sekine, Y, Ouchi, Y, Takei, N, et al. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry 2006;63:90–100.Google Scholar
Srisurapanont, M, Jarusuraisin, N, Jittiwutikan, J. Amphetamine withdrawal: I. Reliability, validity and factor structure of a measure. Aust NZ J Psychiatry 1999;33:89–93.Google Scholar
Dyer, KR, Cruickshank, CC. Depression and other psychological health problems among methamphetamine-dependent patients in treatment: implications for assessment and treatment outcomes. Aust Psychologist 2003;40:96–108.Google Scholar
Scott, JC, Woods, SP, Matt, GE, et al. Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev 2007;17(3):275–297.Google Scholar
Werb, D, Kerr, T, Zhang, R, Montaner, JS, Wood, E. Methamphetamine use and malnutrition among street-involved youth. Harm Reduct J 2010;7:5.Google Scholar
Bhave, PD, Goldschlager, N. An unusual pattern of ST-segment elevation. Arch Intern Med 2011;171(13):1146 (discussion 1147–1148).Google Scholar
Bindoli, A, Rigobello, MP, Deeble, DJ. Biochemical and toxicological properties of the oxidation products of catecholamines. Free Radic Biol Med 1992;13(4):391–405.Google Scholar
Ito, H, Yeo, KK, Wijetunga, M, Seto, TB, Tay, K, Schatz, IJ. A comparison of echocardiographic findings in young adults with cardiomyopathy: with and without a history of methamphetamine abuse. Clin Cardiol 2009;32(6):E18–22.Google Scholar
Jacobs, LJ. Reversible dilated cardiomyopathy induced by methamphetamine. Clin Cardiol 1989;12(12):725–727.Google Scholar
Yeo, K-K, Wijetunga, M, Ito, H, et al. The association of methamphetamine use and cardiomyopathy in young patients. Am J Med 2007;120(2):165–171.Google Scholar
Nishimura, M, Ma, J, Maisel, AS, et al. characteristics and outcomes of methamphetamine abuse among veterans with heart failure. Am J Cardiol 2019;124(6);907–911. doi.org/10.1016/j.amjcard.2019.05.068Google Scholar
Voskoboinik, A, Ihle, JF, Bloom, JE, Kaye, DM. Methamphetamine-associated cardiomyopathy: patterns and predictors of recovery. Intern Med J 2016;46(6):723–727. https://doi.org/10.1111/imj.13050Google Scholar
Callaghan, RC, Cunningham, JK, Sykes, J, Kish, SJ. Increased risk of Parkinson’s disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. Drug Alcohol Depend 2012;120(1–3):35–40. https://doi.org/10.1016/j.drugalcdep.2011.06.013Google Scholar
Chin, KM, Channick, RN, Rubin, LJ. Is methamphetamine use associated with idiopathic pulmonary arterial hypertension? Chest 2006;130(6):1657–1663.Google Scholar
Kamijo, Y, Soma, K, Nishida, M, et al. Acute liver failure following intravenous methamphetamine. Vet Hum Toxicol 2002;44(4):216–217.Google Scholar
Brannan, TA, Soundararajan, S, Houghton, BL. Methamphetamine-associated shock with intestinal infarction. Med Gen Med 2004;6(4):6.Google Scholar
Garcia, E, Waksman, J, Benowitz, N. Methamphetamine-induced pseudovasculitis. Clin Toxicol 2019;57(10);896. doi.org/10.1080/15563650.2019.1636569Google Scholar
Johnson, TD, Berenson, MM. Methamphetamine-induced ischemic colitis. J Clin Gastroenterol 1991;13(6):687–9.Google Scholar
Gonzales, R, Marinelli-Casey, P, Hillhouse, M, et al. Hepatitis A and B infection among methamphetamine-dependent users. J Subst Abus Treat 2008;35(3):351–352.Google Scholar
Scheinmann, R, Hagan, H, Lelutiu-Weinberger, C, et al. Non-injection drug use and hepatitis C virus: a systematic review. Drug Alcohol Depend 2007;89(1):1–12.Google Scholar
Howe, CJ, Fuller, CM, Ompad, DC, et al. Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City. Drug Alcohol Depend 2005;79(3):389–395.Google Scholar
Banooni, P, Rickman, LS, Ward, DM. Pott puffy tumor associated with intranasal methamphetamine. JAMA 2000;283(10):1293.Google Scholar
Wijaya, J, Salu, P, Leblanc, A, et al. Acute unilateral visual loss due to a single intranasal methamphetamine abuse. Bull Soc Belge Ophthalmol 1999;271:19–25.Google Scholar
Shaw, HE Jr, Lawson, JG, Stulting, RD. Amaurosis fugax and retinal vasculitis associated with methamphetamine inhalation. J Clin Neuro Ophthalmol 1985;5(3):169–176.Google Scholar
Baker, A, Lee, NK, Claire, M, et al. Brief cognitive behavioural interventions for regular amphetamine users: a step in the right direction. Addiction 2005;100(3):367–378.Google Scholar
Glasner-Edwards, S, Mooney, LJ, Marinelli-Casey, P, Hillhouse, M, Ang, A, Rawson, RA. Psychopathology in methamphetamine-dependent adults 3 years after treatment. Drug Alcohol Rev 2010;29:12–20.Google Scholar
McKetina, R, Leunga, J, Stockings, E, et al. Mental health outcomes associated with the use of amphetamines: a systematic review and meta-analysis. Clin Med 2019; 16:81–97. https://doi.org/10.1016/j.eclinm.2019.09.014 2589-5370Google Scholar
Stinson, FS, Grant, BF, Dawson, DA, Ruan, WJ, Huang, B, Saha, T. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend 2005;80:105–116.Google Scholar
Conway, KP, Compton, W, Stinson, FS, Grant, BF. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2006;67:247–257.Google Scholar
Sommers, I, Baskin, D, Baskin-Sommers, A. Methamphetamine use among young adults: health and social consequences. Addict Behav 2006;31:1469–1476.Google Scholar
Semple, SJ, Zians, J, Strathdee, SA, Patterson, TL. Psychosocial and behavioural correlates of depressed mood among female methamphetamine users. J Psychoactive Drugs 2007;Suppl. 4:353–366.Google Scholar
Regier, DA, Farmer, ME, Rae, DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264:2511–2518.Google Scholar
McKetin, R, Lubman, DI, Lee, NM, Ross, JE, Slade, TN. Major depression among methamphetamine users entering drug treatment programs. Med J Aust 2011;195(Suppl. 3):S51–SS5.Google Scholar
Rawson, RA, Ling, W. Clinical management: methamphetamine. In: Galanter, M, Kleber, HD, eds., Textbook of Substance Abuse Treatment, 4th ed., pp. 169–179. Washington, DC, American Psychiatric Publishing, 2008.Google Scholar
McKetina, R, Leunga, J, Stockings, E, et al. Mental health outcomes associated with the use of amphetamines: a systematic review and meta-analysis. Clin Med 2019; 16:81–97. https://doi.org/10.1016/j.eclinm.2019.09.0142589-5370Google Scholar
Sommers, I, Baskin, D. Methamphetamine use and violence. J Drug Issues 2006;36:77–96.Google Scholar
Bramness, JG, Gundersen, OH, Guterstam, J, et al. Amphetamine-induced psychosis: a separate diagnostic entity or primary psychosis triggered in the vulnerable? BMC Psychiatry 2012;12:221.Google Scholar
McKetin, R. Methamphetamine psychosis: insights from the past. Addiction 2018;113:1522–1527.Google Scholar
McKetin, R, Dawe, S, Burns, RA, et al. The profile of psychiatric symptoms exacerbated by methamphetamine use. Drug Alcohol Depend 2016;161:104–109.Google Scholar
Chen, CK, Lin, SK, Sham, PC, et al. Pre‐morbid characteristics and co‐morbidity of methamphetamine users with and without psychosis. Psychol Med 2003;33(8):1407–1414. https://doi.org/10.1017/S0033291703008353Google Scholar
Bramness, JG, Gundersen, OH, Guterstam, J, et al. Amphetamine-induced psychosis: a separate diagnostic entity or primary psychosis triggered in the vulnerable? BMC Psychiatry 2012;12:221.Google Scholar
Glasner‐Edwards, S, Mooney, LJ, Marinelli‐Casey, P, Hillhouse, M, Ang, A, Rawson, R. Methamphetamine Treatment Project Corporate, A. Clinical course and outcomes of methamphetamine‐dependent adults with psychosis. J Subst Abuse Treat 2008;35(4):445–450. https://doi.org/10.1016/j.jsat.2007.12.004Google Scholar
Brown, ES, Gabrielson, B. A randomized, double-blind, placebo-controlled trial of citicoline for bipolar and unipolar depression and methamphetamine. J Affect Disord 2012;143(1–3):257–260. https://doi.org/10.1016/j.jad.2012.05.006Google Scholar
Roberts, AR, Yeager, K, Siegel, A. Obsessive-compulsive disorder, comorbid depression, substance abuse, and suicide attempts: clinical presentations, assessments, and treatment. Brief Treat Crisis Interv 2003;3:145–167.Google Scholar
Shoptaw, S, Peck, J, Reback, CJ, Rotheram-Fuller, E. Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment. J Psychoactive Drugs 2003;35:161–168.Google Scholar
Yen, CF, Shieh, BL. Suicidal ideation and correlates in Taiwanese adolescent methamphetamine users. J Nerv Ment Dis 2005;193:444–449.Google Scholar
Bramness, JG, Gundersen, OH, Guterstam, J, et al. Amphetamine-induced psychosis: a separate diagnostic entity or primary psychosis triggered in the vulnerable? BMC Psychiatry 2012;12:221.Google Scholar
Glasner‐Edwards, S, Mooney, LJ, Marinelli‐Casey, P, Hillhouse, M, Ang, A, Rawson, R. Methamphetamine Treatment Project Corporate, A. Clinical course and outcomes of methamphetamine‐dependent adults with psychosis. J Subst Abuse Treat 2008;35(4):445–450. https://doi.org/10.1016/j.jsat.2007.12.004Google Scholar
McKetin, R, Dawe, S, Burns, RA, et al. The profile of psychiatric symptoms exacerbated by methamphetamine use. Drug Alcohol Depend 2016;161:104–109.Google Scholar
Christian, DR, Huber, A, Brecht, ML, et al. Methamphetamine users entering treatment: characteristics of the methamphetamine treatment project sample. Subst Use Misuse 2007;42(14):2207–2222. https://doi.org/10.1080/10826080701209341Google Scholar
Fujii, D. Risk factors for treatment‐resistive methamphetamine psychosis. J Neuropsychiatry Clin Neurosci 2002;14(2):239–240.Google Scholar
Arunogiri, S, Foulds, JA, McKetin, R, Lubman, DI. A systematic review of risk factors for methamphetamine‐associated psychosis. Aust N Z J Psychiatry 2018;52:514–529. https://doi.org/10.1177/0004867417748750Google Scholar
Lecomte, T, Dumais, A, Dugre, JR, Potvin, S. The prevalence of substance‐induced psychotic disorder in methamphetamine misusers: a meta‐analysis. Psychiatry Res 2018;268:189–192. https://doi.org/10.1016/j.psychres.2018.05.033Google Scholar
Ujike, H, Sato, M. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Ann N Y Acad Sci 2004;1025:279–287. https://doi.org/10.1196/annals.1316.035Google Scholar
Srisurapanont, M, Ali, R, Marsden, J, Sunga, A, Wada, K, Monteiro, M. Psychotic symptoms in methamphetamine psychotic in-patients. Int J Neuropsychopharmacol 2003;6(4):347–352.Google Scholar
Arunogiri, S, Foulds, JA, McKetin, R, Lubman, DI. A systematic review of risk factors for methamphetamine-associated psychosis. Aust N Z J Psychiatry 2018;52(6:514–529. https://doi.org/10.1177/0004867417748750Google Scholar
Lecomte, T, Dumais, A, Dugré, JR, Potvin, S. The prevalence of substance-induced psychotic disorder in methamphetamine misusers: a meta-analysis. Psychiatry Res 2018;268:189–192,Google Scholar
Akiyama, K. Longitudinal clinical course following pharmacological treatment of methamphetamine psychosis which persists after long-term abstinence. Ann N Y Acad Sci 2006;1074:125–134.Google Scholar
Chen, CK, Lin, SK, Sham, PC, et al. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychol Med 2003;33:1407–1414.Google Scholar
Dore, G, Sweeting, M. Drug-induced psychosis associated with crystalline methamphetamine. Australas Psychiatry 2006;14:86–89.Google Scholar
Harris, D, Batki, SL. Stimulant psychosis: symptom profile and acute clinical course. Am J Addict 2000;9:28–37.Google Scholar
Srisurapanont, M, Ali, R, Marsden, J, Sunga, A, Wada, K, Monteiro, M. Psychotic symptoms in methamphetamine psychotic in-patients. Int J Neuropsychopharmcol 2003;6:347–352.Google Scholar
Arunogiri, S, McKetin, R, Verdejo-Garcia, A, Lubman, DI. The methamphetamine-associated psychosis spectrum: a clinically focused review. Int J Ment Health Addict 2018 (online). https://doi.org/10.1007/s11469-018-9934-4.Google Scholar
McKetin, R. Methamphetamine psychosis: insights from the past. Addiction 2018;113:1522–1527.Google Scholar
Akiyama, K. Longitudinal clinical course following pharmacological treatment of methamphetamine psychosis which persists after long-term abstinence. Ann N Y Acad Sci 2006;1074:125–134.Google Scholar
Grelotti, DJ, Kanayama, G, Pope, HG Jr. Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature. Am J Psychiatry 2010;167(1):17–23. https://doi.org/10.1176/appi.ajp.2009.08111695Google Scholar
Harris, D, Batki, SL. Stimulant psychosis: symptom profile and acute clinical course. Am J Addict 2000;9:28–37.Google Scholar
Sato, M. Acute exacerbation of methamphetamine psychosis and lasting dopaminergic supersensitivity: a clinical survey. Psychopharmacol Bull 1986;22:751–756.Google Scholar
Sato, M. A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Ann N Y Acad Sci 1992;654:160–170.Google Scholar
Sato, M, Chen, CC, Akiyama, K, Otsuki, S. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol Psychiatry 1983;18:429–440.Google Scholar
Yui, K, Goto, K, Ikemoto, S, Nishijima, K, Yoshino, T, Ishiguro, T. Susceptibility to subsequent episodes of spontaneous recurrence of methamphetamine psychosis. Drug Alcohol Depend 2001;64:133–142.Google Scholar
Takezaki, H, Inotani, T, Ikeda, T, Yasuoka, T. A case of acute recurrent methamphetamine psychosis characterized by fancy delusions of grandeur. Seishin Shinkeigaku Zasshi 1984;86:621–630 [in Japanese].Google Scholar
Teraoka, A. A study on methamphetamine psychosis in a psychiatric clinic: comparison of acute and chronic-type cases. Seishin Shinkeigaku Zasshi 1998;100:425–468 [in Japanese].Google Scholar
Bortolato, M, Frau, R, Piras, AP, et al. Methamphetamine induces long-term alterations in reactivity to environmental stimuli: correlation with dopaminergic and serotonergic toxicity. Neurotox Res 2009;15:232–245.Google Scholar
Wood, DM, Button, J, Ashraf, T, et al. What evidence is there that the UK should tackle the potential emerging threat of methamphetamine toxicity rather than established recreational drugs such as MDMA (‘ecstasy’)? QJM 2008;101(3):207–213. https://doi.org/10.1093/qjmed/hcm133Google Scholar
Hall, MG, Hauson, AO, Wollman, SC, et al. Neuropsychological comparisons of cocaine versus methamphetamine users: a research synthesis and meta-analysis. Am J Drug Alcohol Abuse 2018;44(3):277–293. https://doi.org/10.1080/00952990.2017.1355919Google Scholar
Jernigan, TL, Gamst, AC, Archibald, SL, et al. Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am J Psychiatry 2005;162:1461–1472.Google Scholar
Reback, C, Larkins, S, Shoptaw, S. Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care 2003;15:775–785.Google Scholar
Ellis, RJ, Childers, ME, Cherner, M, Lazzaretto, D, Letendre, S, Grant, I. HIV Neurobehavioral Research Center Group. Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis 2003;188(12):1820–1826.Google Scholar
Cherner, M, Letendre, S, Heaton, RK, et al. Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology 2005;64(8):1343–1347.Google Scholar
Quinn, B, Stoové, M, Dietze, P. One-year changes in methamphetamine use, dependence and remission in a community-recruited cohort. J Subst Use 2015 (online). https://doi.org/10.3109/14659891.2015.10189729Google Scholar
Borders, TF, Booth, BM, Han, X, et al. Longitudinal changes in methamphetamine and cocaine use in untreated rural stimulant users: racial differences and the impact of methamphetamine legislation. Addiction 2008;103:800–808.Google Scholar
Lanyon, C, Nambiar, D, Higgs, P, Dietze, P, Quin, B. Five-year changes in methamphetamine use, dependence, and remission in a community-recruited cohort. J Addict Med 2019;13(2):159–165. https://doi.org/10.1097/ADM.0000000000000469Google Scholar
Mimiaga, MJ, Pantalone, DW, Biello, KB. et al. An initial randomized controlled trial of behavioral activation for treatment of concurrent crystal methamphetamine dependence and sexual risk for HIV acquisition among men who have sex with men. AIDS Care 2019;31(9):1083–1095. doi.org/10.1080/09540121.2019.1595518Google Scholar
Ciketic, S, Hayatbakhsh, R, McKetin, R, Doran, CM, Najman JM. Cost-effectiveness of counselling as a treatment option for methamphetamine dependence. J Subst Use 2015;20(4):239–246.Google Scholar
Vocci, FJ, Montoya, ID. Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence. Curr Opin Psychiatry 2009;22:263–268.Google Scholar
Shoptaw, S, Reback, CJ, Peck, JA, et al. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug Alcohol Depend 2005;78(2):125–134.Google Scholar
Shoptaw, S, Klausner, JD, Reback, CJ, et al. A public health response to the methamphetamine epidemic: the implementation of contingency management to treat methamphetamine dependence. BMC Public Health 2006;6:214.Google Scholar
Rawson, RA, Marinelli-Casey, P, Anglin, MD, et al. A multisite comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction 2004;99:708–717.Google Scholar
Reback, CJ, Peck, JA, Dierst-Davies, R, Nuno, M, Kamien, JB, Amass, L. Contingency management among homeless, out-of-treatment men who have sex with men. J Subst Abuse Treat 2010;39:255–263.Google Scholar
Roll, JM, Petry, NM, Stitzer, ML, et al. Contingency management for the treatment of methamphetamine use disorders. Am J Psychiatry 2006;163:1993–1999.Google Scholar
Rawson, RA, McCann, MJ, Flammino, F, et al. A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals. Addiction 2006;101:267–274. https://doi.org/10.1111/j.1360-0443.2006.01312.xGoogle Scholar
Knapp, WP, Soares, B, Farrell, M, Silva de Lima, M. Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders (review). Cochrane Database Syst Rev (online) 2008;2008:3. https://doi.org/10.1002/14651858.CD003023.Google Scholar
Higgins, ST, Budney, AJ, Bickel, WK, Foerg, FE, Donman, R, Badger, GJ. Incentives improve outcome in outpatient behavioural treatment of cocaine dependence. Arch Gen Psychiatry 1994;51:568–576.Google Scholar
Roll, JM, Huber, A, Sodano, R, et al. A comparison of five reinforcement schedules for use in contingency management-based treatment of methamphetamine users. Psychological Record 2006;56(winter):1.Google Scholar
Ling Murtaugh, K, Krishnamurti, T, Davis, AL, Reback, CJ, Shoptaw, S. Spend today, clean tomorrow: predicting methamphetamine abstinence in a randomized controlled trial. Health Psychol 2013;32(9):958–966. https://doi.org/10.1037/a0032922Google Scholar
Stuart, A, Baker, AL, Bowman, J, et al. Protocol for a systematic review of psychological treatment for methamphetamine use: an analysis of methamphetamine use and mental health symptom outcomes. BMJ Open 2017;7(9):e015383. https://doi.org/10.1136/bmjopen‐2016‐015383Google Scholar
Menza, TW, Jameson, DR, Hughes, JP, Colfax, GN, Shoptaw, S, Golden, MR. Contingency management to reduce methamphetamine use and sexual risk among men who have sex with men: a randomized controlled trial. BMC Public Health 2010;10:774. https://doi.org/10.1186/1471-2458-10-774Google Scholar
McKetina, R, Leunga, J, Stockings, E, et al. Mental health outcomes associated with the use of amphetamines: a systematic review and meta-analysis. Clin Med 2019;16:81–97. https://doi.org/10.1016/j.eclinm.2019.09.014 2589-5370Google Scholar
Graves, SM, Rafeyan, R, Watts, J, Napier, TC. Mirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: evidence from the bench and the bedside. Pharmacol Ther 2012;136(3):343–353. https://doi.org/10.1016/j.pharmthera.2012.08.013Google Scholar
Lee, NK, Rawson, RA. A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug Alcohol Rev 2008;27:309–317.Google Scholar
Lea, T, Kolstee, J, Lambert, S, Ness, R, Hannan, S, Holt, M. Methamphetamine treatment outcomes among gay men attending a LGBTI-specific treatment service in Sydney, Australia. PLOS ONE 2017 (online). https://doi.org/10.1371/journal.pone.0172560Google Scholar
Marshall, BD, Wood, E, Shoveller, JA, et al. Individual, social, and environmental factors associated with initiating methamphetamine injection: implications for drug use and HIV prevention strategies. Prev Sci 2011;12:173–180. https://doi.org/10.1007/s11121-010-0197-yGoogle Scholar
Degenhardt, L, Roxburgh, A, Black, E, et al. The epidemiology of methamphetamine use and harm in Australia. Drug Alcohol Rev 2008;27:243–252. https://doi.org/10.1080/09595230801950572Google Scholar
Damon, W, McNeil, R, Milloy, M-J, Nosova, E, Kerr, T, Hayashi, K. Residential eviction predicts initiation of or relapse into crystal methamphetamine use among people who inject drugs: a prospective cohort study. J Public Health 2019;41(1):36–45. https://doi.org/10.1093/pubmed/fdx187Google Scholar
Morris, L, Stander, J, Ebrahim, W, et al. Effect of exercise versus cognitive behavioural therapy or no intervention on anxiety, depression, fitness and quality of life in adults with previous methamphetamine dependency: a systematic review. Addict Sci Clin Pract 2018;13:4.Google Scholar
Ahmadi, J. Comparison of electroconvulsive therapy, buprenorphine and methadone in the management of methamphetamine dependency and withdrawal craving. J Addict Depend 2016;2:1–3. https://doi.org/10.15436/2471‐061X‐16‐031Google Scholar
Ahmadi, J, Ekramzadeh, S, Pridmore, S. Remission of methamphetamine‐induced withdrawal delirium and craving after electroconvulsive therapy. Iran J Psychiatr Behav Sci 2015;9(4):e1793.https://doi.org/10.17795/ijpbs‐1793Google Scholar
Grelotti, DJ, Kanayama, G, Pope, HG. Jr. Remission of persistent methamphetamine‐induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature. Am J Psychiatry 2010;167(1):17–23. https://doi.org/10.1176/appi.ajp.2009.08111695Google Scholar
Zeng, L, Tao, Y, Hou, W, Zong, L, Yu, L. Electro‐acupuncture improves psychiatric symptoms, anxiety and depression in methamphetamine addicts during abstinence: a randomized controlled trial. Medicine 2018;97(34):e11905. https://doi.org/10.1097/MD.0000000000011905Google Scholar
Liang, Y, Zhang, X, Xu, B, Zong, L. Clinical observation of electroacupuncture for withdrawal symptoms in methamphetamine addicts. Int J Clin Acupunct 2015;24(4):236–241.Google Scholar
Zemestani, M, Ottaviani, C. Effectiveness of mindfulness‐based relapse prevention for co‐occurring substance use and depression disorders. Mindfulness 2016;7(6):1347–1355. https://doi.org/10.1007/ s12671‐016‐0576‐yGoogle Scholar
Glasner, S, Mooney, LJ, Ang, A, et al. Mindfulness-based relapse prevention for stimulant-dependent adults: a pilot randomized clinical trial. Mindfulness 2017;8(1):126–135.Google Scholar
National Institute of Drug Abuse (NIDA). What treatments are effective for people who abuse methamphetamine? Available at: www.drugabuse.gov/publications/research-reports/methamphetamine/what-treatments-are-effective-methamphetamine-abusers [last accessed 15 March 2022].Google Scholar
Collins, KC, Schlosburg, JE, Bremer, PT, Janda, KD. Methamphetamine vaccines: improvement through hapten design. J Med Chem 2016;59:3878–3885.Google Scholar
Elkashef, A, Kahn, R, Yu, E, et al. Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial. Addiction 2012;107(7):1297–1306. https://doi.org/10.1111/j.1360-0443.2011.03771.xGoogle Scholar
McElhiney, MC, Rabkin, JG, Rabkin, R, Nunes, EV. Provigil (modafinil) plus cognitive behavioral therapy for methamphetamine use in HIV+ gay men: a pilot study. Am J Drug Alcohol Abuse 2009;35(1):34–7. https://doi.org/10.1080/00952990802342907Google Scholar
Piasecki, M, Steinagel, G, Thienhaus, O, Kohlenberg, B. An exploratory study: the use of paroxetine for methamphetamine craving. J Psychoactive Drugs 2002;34:301–304.Google Scholar
Elkashef, AM, Rawson, RA, Anderson, AL, et al. Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology 2008;33(5):1162–1170.Google Scholar
Shoptaw, S, Huber, A, Peck, J, et al. Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence. Drug Alcohol Depend 2006;85:12–18.Google Scholar
Shoptaw, S, Heinzerling, KG, Rotheram-Fuller, E, et al. Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend 2008;96:222–232.Google Scholar
McCann, DJ, Li, SH. A novel, nonbinary evaluation of success and failure reveals bupropion efficacy versus methamphetamine dependence: reanalysis of a multisite trial. CNS Neurosci Ther 2012;18(5):414–418. https://doi.org/10.1111/j.1755-5949.2011.00263.xGoogle Scholar
Brensilver, M, Heinzerling, KG, Swanson, A-N, Shoptaw, SJ. A retrospective analysis of two randomized trials of bupropion for methamphetamine dependence: suggested guidelines for treatment discontinuation/augmentation. Drug Alcohol Depend 2012;125:169–172.Google Scholar
Kenford, SL, Fiore, MC, Jorenby, DE, Smith, SS, Wetter, D, Baker, TB. Predicting smoking cessation. JAMA 1994;271:589.Google Scholar
Plebani, JG, Kampman, KM, Lynch, KG. Early abstinence in cocaine pharmacotherapy trials predicts successful treatment outcomes. J Subst Abuse Treat 2009;37:313–317.Google Scholar
Urschel, HC III, Hanselka, LL, Baron, M. A controlled trial of flumazenil and gabapentin for initial treatment of methylamphetamine dependence. J Psychopharmacol 2011;25:254–262.Google Scholar
Grant, JE, Odlaug, BL, Kim, SW. A double-blind, placebo-controlled study of N-acetylcysteine plus naltrexone for methamphetamine dependence. Eur Neuropsychopharmacol 2010;20:823–828.Google Scholar
McGregor, C, Srisurapanont, M, Mitchell, A, Wickes, W, White, JM. Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usual. J Subst Abuse Treat 2008;35:334–342.Google Scholar
Cruickshank, CC, Montebello, ME, Dyer, KR, et al. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal. Drug Alcohol Rev 2008;27(3):326–333.Google Scholar
Laqueille, X, Dervaux, A, El Omari, F, Kanit, M, Bayle, FJ. Methylphenidate effective in treating amphetamine abusers with no other psychiatric disorder. Eur Psychiatry 2005;20:456–457.Google Scholar
De La Garza, R II, Newton, TF, Haile, CN, et al. Rivastigmine reduces ‘likely to use methamphetamine’ in methamphetamine-dependent volunteers. Prog Neuropsychopharmacol Biol Psychiatry 2012;37:141–146.Google Scholar
Siefried, KJ, Acheson, LS, Lintzeris, N, et al. Pharmacological treatment of methamphetamine/amphetamine dependence: a systematic review. CNS Drugs 2020;34:337–365. https://doi.org/10.1007/s40263-020-00711-xGoogle Scholar
Siefried, KJ, Acheson, LS, Lintzeris, N, et al. Pharmacological treatment of methamphetamine/amphetamine dependence: a systematic review. CNS Drugs 2020;34:337–365. https://doi.org/10.1007/s40263-020-00711-xGoogle Scholar
Morley, KC, Cornish, JL, Faingold, A, Wood, K, Haber, PS. Pharmacotherapeutic agents in the treatment of methamphetamine dependence. Exp Opin Investig Drugs 2017;26(5):563–578. https://doi.org/10.1080/13543784.2017.1313229Google Scholar
Chan, B, Kansagara, D, Kondo, K, et al.Amphetamine use disorder: a systematic review and meta-analysis. J Gen Intern Med 2019;34(2):2122–2136.doi.org/10.1007/11606.1525-1497Google Scholar
Chan, B, Kansagara, D, Kondo, K, et al.Amphetamine use disorder: a systematic review and meta-analysis. J Gen Intern Med 2019;34(2):2122–2136.Google Scholar
Chan, B, Freeman, M, Kondo, K, et al. Pharmacotherapy for methamphetamine/amphetamine use disorder: a systematic review and meta-analysis. Addiction 2019 (online). https://doi.org/10.1111/add.14755Google Scholar
Ahmadi, J, Sahraian, A, Biuseh M. A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving. Trials 2019;20:468. https://doi.org/10.1186/s13063-019-3554-6Google Scholar
Pérez-Mañá, C, Castells, X, Torrens, M, Capellà, D, Farre, M. Efficacy of psychostimulant drugs for amphetamine abuse or dependence (review). Cochrane Database Syst Rev 2013;9:CD009695. https://doi.org/10.1002/14651858.CD009695.pub2Google Scholar
Siefried, KJ, Acheson, LS, Lintzeris, N, et al. Pharmacological treatment of methamphetamine/amphetamine dependence: a systematic review. CNS Drugs 2020;34:337–365. https://doi.org/10.1007/s40263-020-00711-xGoogle Scholar
Chan, B, Freeman, M, Kondo, K, et al. Pharmacotherapy for methamphetamine/amphetamine use disorder: a systematic review and meta-analysis. Addiction 2019 (online). https://doi.org/10.1111/add.14755Google Scholar
Coffin, PO, Santos, GM, Hern, J, et al. Extended-release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo-controlled trial. Addiction 2018;113:268–278.Google Scholar
Trivedi, MH, Walker, R, Ling, W, et al.Bupropion and naltrexone in methamphetamine use disorder. N Engl J Med 2021;384:2.Google Scholar
Lim, AC, Grodin, EN, Green, R, et al. Executive function moderates naltrexone effects on methamphetamine-induced craving and subjective responses. Am J Drug Alcohol Abuse 2020 (online). https://doi.org/10.1080/00952990.2020.1741002Google Scholar
Batki, SL, Moon, J, Bradley, M, et al. Fluoxetine in methamphetamine dependence. A controlled trial: a preliminary analysis. CPDD 61st Annual Scientific Meeting. Acapulco, June 1999.Google Scholar
Batki, SL, Moon, J, Delucchi, K, et al. Methamphetamine quantitative urine concentrations during a controlled trial of fluoxetine treatment. Preliminary analysis. Ann N Y Acad Sci 2000;909:260–263.Google Scholar
Kongsakon, R, Papadopoulos, KI, Saguansiritham, R. Mirtazapine in amphetamine detoxification: a placebo-controlled pilot study. Int Clin Psychopharmacol 2005;20:253–256.Google Scholar
Ling, W, Shoptaw, S, Hillhouse, M, et al. Double-blind placebo-controlled evaluation of the PROMETA™ protocol for methamphetamine dependence. Addiction 2012;107(2):361–369. https://doi.org10.1111/j.1360-0443.2011.03619.xGoogle Scholar
Bhatt, M, Zielinski, L, Baker-Beal, L, et al.Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis. Syst Rev 2016;5:189. https://doi.org/10.1186/s13643-016-0370-xGoogle Scholar
Chan, B, Kansagara, D, Kondo, K, et al.Amphetamine use disorder: a systematic review and meta-analysis. J Gen Int Med 2019;34(2):2122–2136. doi.org/10.1007/11606.1525-1497Google Scholar
Brecht, ML, Greenwell, L, Anglin, MD. Methamphetamine treatment: trends and predictors of retention andcompletion in a large state treatment system (1992–2002). J Subst Abuse Treat 2005;29(4):295–306.Google Scholar
Otero, C, Boles, S, Young, N, Dennis, K. Methamphetamine Addiction, Treatment, and Outcomes: Implications for Child Welfare Workers. Washington, DC, Substance Abuse and Mental Health Services Administration (SAMSHA), Center for Substance Abuse Treatment, 2006.Google Scholar
Rawson, R, Huber, A, Brethen, P, et al. Methamphetamine and cocaine users: differences in characteristics and treatment retention. J Psychoactive Drugs 2000;32:233−238.Google Scholar
Embry, D, Hankins, M, Biglan, A, Boles, S. Behavioral and social correlates of methamphetamine use in a population-based sample of early and later adolescents. Addict Behav 2009;34:343–351.Google Scholar
Šefránek, M, Miovský, M. Treatment outcome evaluation in therapeutic communities in the Czech Republic: alcohol consumption and other results one year after discharge. Alcohol Treat Q 2018;36(1):54–71.Google Scholar
Kamp, F, Proebst, L, Hager, L, et al. Effectiveness of methamphetamine abuse treatment: predictors of treatment completion and comparison of two residential treatment programs. Drug Alcohol Depend 2019;201:8–15Google Scholar
Jaffe, A, Shoptaw, S, Stein, J, Reback, CJ, Rotheram-Fuller, E. Depression ratings, reported sexual risk behaviors, and methamphetamine use: latent growth curve models of positive change among gay and bisexual men in an outpatient treatment program. Exp Clin Psychopharmacol 2007;15(3):301–307.Google Scholar
Rawson, RA, Gonzales, R, Pearce, V, Ang, A, Marinelli-Casey, P, Brummer, J. Methamphetamine Treatment Project Corporate Authors. Methamphetamine dependence and human immunodeficiency virus risk behaviour. J Subst Abuse Treat 2008;35(3):279–284. https://doi.org/10.1016/j.jsat.2007.11.003Google Scholar
Brecht, ML, Greenwell, L, von Mayrhauser, C, Anglin, MD. Two-year outcomes of treatment for methamphetamine use. J Psychoactive Drugs 2006;Suppl. 3:415–426.Google Scholar
Hillhouse, MP, Marinelli-Casey, P, Gonzales, R, Ang, A, Rawson, RA. Predicting in-treatment performance and post-treatment outcomes inmethamphetamine users. Addiction 2007;102(Suppl. 1):84–95.Google Scholar
Brecht, ML, von Mayrhauser, C, Anglin, MD. Predictors of relapse after treatment for methamphetamine use. J Psychoactive Drugs 2000;32:211–220.Google Scholar
Maglione, M, Chao, B, Anglin, MD. Correlates of outpatient drug treatment drop-out among methamphetamine users. J Psychoactive Drugs 2000;32:221–228.Google Scholar
Maglione, M, Chao, B, Anglin, D. Residential treatment of methamphetamine users: correlates of drop-out from the California alcohol and drug data system (CADDS). Addict Res 2000;8:65–79.Google Scholar
Quinn, B, Stoové, M, Dietze, P. One-year changes in methamphetamine use, dependence and remission in a community-recruited cohort. J Subst Use 2015 (online). https://doi.org/10.3109/14659891.2015.1018972Google Scholar
Quinn, B, Stoové, M, Dietze, P. One-year changes in methamphetamine use, dependence and remission in a community-recruited cohort. J Subst Use 2015 (online). https://doi.org/10.3109/14659891.2015.1018972Google Scholar
Quinn, B, Stoové, M, Dietze, P. One-year changes in methamphetamine use, dependence and remission in a community-recruited cohort. J Subst Use 2015 (online). https://doi.org/10.3109/14659891.2015.1018972Google Scholar
Quinn, B, Stoové, M, Dietze, P. One-year changes in methamphetamine use, dependence and remission in a community-recruited cohort. J Subst Use 2015 (online). https://doi.org/10.3109/14659891.2015.1018972Google Scholar
Gonzales, R, Ang, A, Marinelli-Casey, P, Glik, DC, Iguchi, MY, Rawson, RA. Methamphetamine Treatment Project Corporate Authors. Health-related quality of life trajectories of methamphetamine-dependent individuals as a function of treatment completion and continued care over a 1-year period. J Subst Abuse Treat 2009;37(4):353–361. https://doi.org/10.1016/j.jsat.2009.04.001Google Scholar
Dean, AC, London, ED, Sugar, CA, et al. Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables. Drug Alcohol Depend 2009;105(1–2):48–55. https://doi.org/10.1016/j. drugalcdep.2009.06.008Google Scholar
Peterson, JD, Wolf, ME, White, FJ. Repeated amphetamine administration decreases D1 dopamine receptor-mediated inhibition of voltage-gated sodium currents in the prefrontal cortex. J Neurosci 2006;26:3164–3168.Google Scholar
Lee, N, Pennay, A, Kenny, P, Harney, A, Johns, L. Methamphetamine withdrawal: natural history and options for intervention. Australasian Society for Psychiatric Research Annual Meeting. Sydney, Brainwaves, 2006.Google Scholar
Gonzalez Castro, F, Barrington, EH, Walton, MA, Rawson, RA. Cocaine and methamphetamine: differential addiction rates. Psychol Addict Behav 2000;14(4):390–396.Google Scholar
Simon, S, Richardson, K, Dacey, J, et al. A comparison of patterns of methamphetamine and cocaine use. J Addict Dis 2002;21(1):35–44.Google Scholar
Kenny, P, Harney, A, Lee, NK, Pennay, A. Teatment utilization and barriers to treatment: results of a survey of dependent methamphetamine users. Subst Abuse Treat Prevent Policy 2011;6:3.Google Scholar
McKetin, R, McLaren, J, Kelly, E, Hall, W, Hickman, M. Estimating the Number of Regular and Dependent Methamphetamine Users in Australia (Technical Report No. 230). Sydney, NDARC, UNSW, 2005.Google Scholar
Australian Institute of Health and Welfare. Alcohol and Other Drug Treatment Services in Australia 2007–2009: Report on the National Minimum Data Set (Drug treatment series no. 9. Cat. no. HSE 73). Canberra, AIHW, 2009.Google Scholar
Pennay, A, Lee, N. Barriers to methamphetamine withdrawal treatment in Australia: findings from a survey of AOD service providers. Drug Alcohol Rev 2009;28(1):636–640.Google Scholar
Saltman, DC, Newman, CE, Mao, L, Kippax, SC, Kidd, MR. Experiences in managing problematic crystal methamphetamine use and associated depression in gay men and HIV positive men: in-depth interviews with general practitioners in Sydney, Australia. BMC Fam Pract 2008;9(45):1–7.Google Scholar
Quinn, B, Stoové, M, Dietze, P. Factors associated with professional support access among a prospective cohort of methamphetamine users. J Subst Abuse Treat 2013;45:235–241.Google Scholar
Darke, S, Ross, J, Teesson, M, Lynskey, M. Health service utilization and benzodiazepine use among heroin users: findings from the Australian Treatment Outcome Study (ATOS). Addiction 2003;98(8):1129–1135.Google Scholar
Pennay, A, Ferris, J, Reed, M, Devaney, M, Lee, N. Evaluation of ‘Access Point’ Specialist Methamphetamine Clinic. Fitzroy, Melbourne, Turning Point Alcohol and Drug Centre, 2010.Google Scholar
Kelly, E, McKetin, R, McLaren, J. Health Service Utilisation Among Regular Methamphetamine Users (Vol. Technical Report No. 233). Sydney, National Drug and Alcohol Research Centre, 2005.Google Scholar
McKetin, R, Kelly, E. Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia. Drug Alcohol Rev 2007;26:161–168.Google Scholar
Lea, T, Mao, L, Hopwood, M, et al. Methamphetamine use among gay and bisexual men in Australia: trends in recent and regular use from the Gay Community Periodic Surveys. Int J Drug Policy 2016;29:66–72.Google Scholar
Hando, J, Topp, L, Hall, W. Amphetamine-related harms and treatment preferences of regular amphetamine users in Sydney, Australia. Drug Alcohol Depend 1997;46:105–113.Google Scholar
Degenhardt, L, Sara, G, Mcketin, R, et al. Crystalline methamphetamine use and methamphetamine-related harms in Australia. Drug Alcohol Rev 2016 (online). https://doi.org/10.1111/dar.12426Google Scholar
Degenhardt, L, Sara, G, Mcketin, R, et al. Crystalline methamphetamine use and methamphetamine-related harms in Australia. Drug Alcohol Rev 2016 (online). https://doi.org/10.1111/dar.12426Google Scholar
Lemos, NP. Methamphetamine and driving. Social Sci Justice 2009;49:247–249.Google Scholar
Degenhardt, L, Sara, G, Mcketin, R, et al. Crystalline methamphetamine use and methamphetamine-related harms in Australia. Drug Alcohol Rev 2016 (online). https://doi.org/10.1111/dar.12426Google Scholar

Accessibility standard: Unknown

Accessibility compliance for the PDF of this book is currently unknown and may be updated in the future.

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×